Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Author: Admin
NEW YORK — NEW YORK (AP) â The union representing Broadway’s musicians reached a tentative labor agreement with commercial producers on Thursday, averting a potentially crippling strike that would have silenced nearly two dozen musicals.The American Federation of Musicians Local 802 â which represents 1,200 musicians â had threatened to strike if they didnât have a new contract by the morning, after going into mediation Wednesday.Early Thursday, the union said it had struck a tentative deal that includes wage increases and contribution increases to the health fund. “This three-year agreement provides meaningful wage and health benefit increases that will preserve…
A Manchester concert by controversial punk rap duo Bob Vylan has been postponed, following calls by Jewish leaders and MPs for it to be cancelled. The band, which led a crowd in chants of “death to the IDF” (Israel Defence Forces) during an appearance at Glastonbury music festival this summer, had been due to play at the Manchester Academy early next month. According to correspondence, seen by Sky News, the venue has rescheduled the gig for next year.It comes after the Jewish Representative Council (JRC) of Greater Manchester – backed by 10 MPs – wrote to the Manchester Academy asking them…
SAN DIEGO, Oct. 23, 2025 /PRNewswire/ — Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, today announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s monoclonal antibodies (mAbs) that targets a cancer of high clinical unmet need. The antibody will strengthen Orion’s broad oncology-focused drug Research and Development (R&D) pipeline. The antibody was designed and developed at Abzena’s Cambridge, UK, early phase R&D facility using their proprietary Composite Human Antibody (CHAbâą) technology as part of an integrated developability platform approach to select a superior lead candidate. Abzena’s scientists screened antibodies against a number…
NEW YORK, Oct. 23, 2025 /PRNewswire/ — BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery technologies, has launched a 15-day dosing optimization study for its lead product BNT23001, a proprietary sublingual Cladribine formulation for the treatment of multiple sclerosis (MS).The study marks the final step before human bioequivalence testing, which is set to begin in early 2026. BioNxt Enters the Final Stretch Before Human Trials for Next-Generation MS Drug A Final Step Before Human Testing Following successful small-animal trials that confirmed bioequivalence, BioNxt is…
Strictly Come Dancing presenters Tess Daly and Claudia Winkleman have announced they will be leaving the show.The pair made the announcement in a joint video shared on social media, saying they would enjoy the rest of the “amazing” current series before bowing out together and passing on “the very sparkly baton” to new hosts. “After 21 unforgettable years, the time has come to say goodbye to Strictly Come Dancing,” Daly wrote in a post on Instagram.”Strictly has always been about joy, celebration and bringing people together – and I’m so proud to have played a small part in something that…
ZHANGSHU, China, Oct. 23, 2025 /PRNewswire/ — A report from Jiangxi International Communication Center (JXICC): “Without Zhangshu, medicines are incomplete; without Zhangshu, medicines lack efficacy.” On October 16, 2025, Jiangxi’s Zhangshu Qihuang Town was bustling with crowds as the 56th National Medicinal Materials and Pharmaceuticals Trade Fair grandly opened here. Simultaneously, an international youth exploration journey in Jiangxi, themed “From Ancient Wisdom to Modern Wellness,” was launched. This event was jointly organized by the Jiangxi International Communication Center and Jiangxi University of Chinese Medicine, hosted by the Jiangxi Daily Exhibition Business Department, and co-organized by Renhe Group. It invited ten international students from multiple…
NEW YORK — NEW YORK (AP) â Decades into his career and the unthinkable happened. It was 2022, and Jon Bon Jovi began struggling through his songs. He saw a doctor who said one of his vocal cords was atrophying. He needed major surgery. Bon Jovi had the procedure, and in the years since, has undergone extensive rehab, leading to the current moment: Next summer his band, Bon Jovi, will embark on their first tour in four years.The âForever Tourâ kicks off with four nights at New York’s Madison Square Garden before the band heads to Edinburgh, Scotland; Dublin and…
The plot of the new Colleen Hoover adaptation âRegretting Youâ is a little wild. Thereâs romance, an affair, unrequited love, death and even a baby with questionable paternity.Dave Franco, whose character has long pined for Allison Williamsâ character but ends up having a child with her sister who is having an affair with her brother-in-law, said someone recently exclaimed to him, âWhat in the Maury Povich was that?âTabloid talk show fodder though they might be, Hooverâs novels have hit a nerve with audiences and Hollywood. âIt Ends With Usâ made over $350 million worldwide against a $25 million budget and…
STOCKHOLM, Oct. 23, 2025 /PRNewswire/ — Hygiene and health company Essity is today launching measures to create better conditions for profitable growth. Actions include an organizational change that decentralizes decision-making and strengthens end-to-end accountability for each product category, and a cost savings program that is expected to generate annual savings of approximately SEK 1bn with full effect by the end of 2026. “Today, we’re launching measures to create better conditions for Essity to increase its growth rate going forward and to faster achieve our targets,” says Ulrika Kolsrud, President and CEO, Essity. The organizational change will simplify Essity’s structure and create…
SĂO PAULO, Oct. 22, 2025 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing essential tools and technologies to drive innovation in the life sciences, has entered into a strategic partnership with Eva Holding Group, a Brazilian group operating in genomics applied to human health, animal health, and agribusiness. The initiative aims to expand Brazilian patients’ access to genomics, including joint efforts in the development of the country’s genetic sector. DNBSEQ-T7 The agreement includes the installation of genetic sequencers that expand public access to cutting-edge genomic technologies and enhance the accuracy…
